NDC 45802-737-01 - clindamycin and benzoyl peroxide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 45802-737
- Requested NDC
- 45802-737-01
- Package NDCs from labels
- 45802-737-01
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Effective date
- 2025-05-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| clindamycin and benzoyl peroxide - Padagis Israel Pharmaceuticals Ltd | Padagis Israel Pharmaceuticals Ltd | 2025-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45802-737-01 | clindamycin and benzoyl peroxide | 0.3 g in 1 VIAL | POWDER, FOR SOLUTION | 0.3 g | 10 mg in 1g | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium | DOCUSATE SODIUM | Belleview Bio Science | 335f41d7-5c22-7c17-e063-6294a90a8f28 | 2025-04-22 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | e5028f6d-d33d-47a9-8453-00af5cdf59a6 | 2025-04-20 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Oral Liquid | DOCUSATE SODIUM ORAL LIQUID | Kesin Pharma Corporation | 331277b8-8304-d082-e063-6394a90a4dd3 | 2025-04-18 | Warnings | F05Q2T2JA0 |
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
| Senna-S | SENNOSIDES AND DOCUSATE SODIUM | Meijer, Inc. | 2619be6e-877b-16a2-e063-6394a90a68da | 2025-03-24 | Warnings | F05Q2T2JA0 |
| Stool Softener plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Meijer, Inc. | 261a88d6-87d2-7544-e063-6294a90a2e94 | 2025-03-24 | Warnings | F05Q2T2JA0 |
| CVS Health Stool Softener Plus stimulant laxative Softgel | DOCUSATE SODIUM, SENNOSIDES | CVS Pharmacy, Inc | 2881d83d-9929-677a-e063-6394a90a0424 | 2025-03-19 | Warnings | F05Q2T2JA0 |
| CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Alembic Pharmaceuticals Limited | 41ab7061-7c3a-4a4c-9c44-16851c97ad00 | 2025-03-03 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Mayne Pharma | c7381600-2e4c-4e7b-aa67-fe7d5fae7b40 | 2025-02-28 | Warnings, Adverse reactions | W9WZN9A0GM EH6D7113I8 |
| AeroWash Eyewash | EYEWASH SOLUTION | Aero Healthcare US LLC | a477de08-4301-0ee5-e053-2995a90af79d | 2025-02-26 | Warnings | 059QF0KO0R |
| Se-Natal 19 | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM PANTOTHENATE, CALCIUM CARBONATE, FERROUS FUMARATE, ZINC OXIDE AND DOCUSATE SODIUM | Seton Pharmaceuticals | 635104e6-6a53-4684-ac9a-7ac31b33083d | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | F05Q2T2JA0 |
| Advanced Eye Relief Eye Wash | WATER SOLUTION | Bausch & Lomb Incorporated | 9caccce1-4530-441d-bf76-244edeb9dedc | 2025-02-17 | Warnings | 059QF0KO0R |
| Stool Softener and Stimulant Laxative | DOCUSATE SODIUM, SENNOSIDES | H-E-B | c19280c2-f968-b582-e053-2995a90a9bd3 | 2025-02-14 | Warnings | F05Q2T2JA0 |
| STOOL SOFTENER-STIMULANT LAXATIVE | STOOL SOFTENER-STIMULANT LAXATIVE | Kroger Company | a22c9f95-e3a9-bfd3-e053-2995a90a3c66 | 2025-02-13 | Warnings | F05Q2T2JA0 |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | KROGER | a187045c-c9d6-592a-e053-2995a90adb83 | 2025-02-10 | Warnings | F05Q2T2JA0 |
| SENNA TIME S | DOCUSATE SODIUM-SENNOSIDES | TIME CAP LABORATORIES, INC | dc491692-8d3a-4ccd-a17d-4c630f122595 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| SENNOSIDES AND DOCUSATE SODIUM | SENNOSIDES AND DOCUSATE SODIUM | TIME CAP LABORATORIES, INC | 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Asclemed USA, Inc. | 2db546de-20dc-4697-aff2-12471f073b1d | 2025-02-08 | Warnings | F05Q2T2JA0 |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products, Inc. | 2d90c8e8-f479-3535-e063-6394a90af122 | 2025-02-07 | Warnings | 059QF0KO0R |
| Docusate Sodium | DOCUSATE SODIUM | PAI Holdings, LLC dba PAI Pharma | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 2025-02-06 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.